These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 19331800)

  • 21. Germacrone reverses adriamycin resistance in human chronic myelogenous leukemia K562/ADM cells by suppressing MDR1 gene/P-glycoprotein expression.
    Pan J; Miao D; Chen L
    Chem Biol Interact; 2018 May; 288():32-37. PubMed ID: 29655913
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Studies on the effects of Siwu Mixture on reversing multidrug resistance of human erythrocyte leukemic cell line K562/ADM].
    Xia L; Shen P
    Zhongguo Zhong Yao Za Zhi; 2004 Aug; 29(8):792-5. PubMed ID: 15506297
    [TBL] [Abstract][Full Text] [Related]  

  • 23. AZT and emodin exhibit synergistic growth-inhibitory effects on K562/ADM cells by inducing S phase cell cycle arrest and suppressing MDR1 mRNA/p-gp protein expression.
    Chen P; Liu Y; Sun Y; Chen C; Qi Y; Zhang Y
    Pharm Biol; 2013 Dec; 51(12):1586-91. PubMed ID: 24004004
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Potentiation of harringtonine cytotoxicity by calcium antagonist diltiazem and biscoclaurine alkaloid cepharanthine in adriamycin-resistant P388 murine leukemia and K562 human leukemia cells.
    Yamamoto S; Hui PZ; Fukuda Y; Tatsumi K; Mino M
    Biochem Int; 1989 Jun; 18(6):1077-83. PubMed ID: 2751676
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Effect of phenylhexyl isothiocyanate on adriamycin resistance of K562/A02 cell line].
    Yuang P; Chen BA; Cheng J; Ma XD; Liu DL; Lu QY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Apr; 17(2):352-7. PubMed ID: 19379565
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sensitization and apoptosis augmentation of K562/ADM cells by anti-multidrug resistance gene peptide nucleic acid and antisense oligodeoxyribonucleotide.
    Wei HL; Wu YJ; Jing T; Bai DC; Ma LF
    Acta Pharmacol Sin; 2003 Aug; 24(8):805-11. PubMed ID: 12904281
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MDR reversal activity of bromotetrandrine in vitro and in vivo.
    Cheng J; Wang JQ; Chen BA; Gao F; Xu WL; Shen HL; Ding JH; Gao C; Sun YY; Wang J; Zhao G; Song HH; Bao W; Sun Q; Dai YY; Sun XC; Cheng HY; Deng YX; Li GH; Chen NN; Liu LJ; Wang XM
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Oct; 17(5):1183-91. PubMed ID: 19840447
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cross-resistance to tumour promoters in human cancer cell lines resistant to adriamycin or cisplatin.
    Nishio K; Sugimoto Y; Nakagawa K; Niimi S; Fujiwara Y; Bungo M; Kasahara K; Fujiki H; Saijo N
    Br J Cancer; 1990 Sep; 62(3):415-9. PubMed ID: 2206949
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of Compound Zhebei Granule () Combined with Doxorubicin on Expression of Specific Surface Antigens in Mice with Transplanted KG-1a Cells.
    Zhang Y; Hou L; Chen XY
    Chin J Integr Med; 2018 Mar; 24(3):213-217. PubMed ID: 28986815
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro evaluation of the new anticancer agents KT6149, MX-2, SM5887, menogaril, and liblomycin using cisplatin- or adriamycin-resistant human cancer cell lines.
    Ohe Y; Nakagawa K; Fujiwara Y; Sasaki Y; Minato K; Bungo M; Niimi S; Horichi N; Fukuda M; Saijo N
    Cancer Res; 1989 Aug; 49(15):4098-102. PubMed ID: 2472873
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The combination of recombinant rAd-p53 and adriamycin for management of primary drug resistance in chemotherapy of lung squamous cell cancer].
    Du CH; Wu Z; Xu J
    Zhonghua Jie He He Hu Xi Za Zhi; 2006 Sep; 29(9):622-4. PubMed ID: 17129471
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Arsenic trioxide inhibits P-glycoprotein expression in multidrug-resistant human leukemia K562/ADM cell line that overexpresses mdr-1 gene and enhances their chemotherapeutic sensitivity].
    Wei HL; Yao XJ; Li YN; Wang P; Zhao HS; Bai DC; Peng X; Ma LF
    Zhonghua Xue Ye Xue Za Zhi; 2003 Jan; 24(1):28-31. PubMed ID: 12679007
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Effect of compound Zhe-Bei granule (CZBG) combined with doxorubicin on cell apoptosis and expression of related proteins in K562/A02 multidrug resistance tumor xenografts in mice].
    Chen XY; Zheng Z; Chen J; Li DY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Dec; 17(6):1439-42. PubMed ID: 20030922
    [TBL] [Abstract][Full Text] [Related]  

  • 34. B4GALT1 gene knockdown inhibits the hedgehog pathway and reverses multidrug resistance in the human leukemia K562/adriamycin-resistant cell line.
    Zhou H; Zhang Z; Liu C; Jin C; Zhang J; Miao X; Jia L
    IUBMB Life; 2012 Nov; 64(11):889-900. PubMed ID: 23024026
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of phosphatase and tensin homology deleted on chromosome 10 (PTEN) gene transfection on reversal of multidrug resistance in K562/ADM cells.
    Cheng Z; Yang N; Liang W; Yan X; Li L; Pan L
    Leuk Lymphoma; 2012 Jul; 53(7):1383-9. PubMed ID: 22185283
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enhanced therapeutic effects on the multi-drug resistant human leukemia cells in vitro and xenograft in mice using the stealthy liposomal vincristine plus quinacrine.
    Liang GW; Lu WL; Wu JW; Zhao JH; Hong HY; Long C; Li T; Zhang YT; Zhang H; Wang JC; Zhang X; Zhang Q
    Fundam Clin Pharmacol; 2008 Aug; 22(4):429-37. PubMed ID: 18705753
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Establishment of a human leukemia subline resistant to the growth-inhibitory effect of 12-O-tetradecanoylphorbol 13-acetate (TPA) and showing non-P-glycoprotein-mediated multi-drug resistance.
    Takeda Y; Nishio K; Sugimoto Y; Kasahara K; Kubo S; Fujiwara Y; Niitani H; Saijo N
    Int J Cancer; 1991 Jul; 48(6):931-7. PubMed ID: 1677641
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cyclosporine diminishes multidrug resistance in K562/ADM cells and improves complete remission in patients with acute myeloid leukemia.
    Li GY; Liu JZ; Zhang B; Wang LX; Wang CB; Chen SG
    Biomed Pharmacother; 2009 Sep; 63(8):566-70. PubMed ID: 19095404
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characteristics of resistance to adriamycin in human myelogenous leukemia K562 resistant to adriamycin and in isolated clones.
    Tsuruo T; Iida-Saito H; Kawabata H; Oh-hara T; Hamada H; Utakoji T
    Jpn J Cancer Res; 1986 Jul; 77(7):682-92. PubMed ID: 3091555
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Effect of desferrioxamine on K562/A02 cell line and its mechanism].
    Cheng J; Wang T; Chen BA; Ding JH; Gao C; Xia GH; Bao W; Song HH; Xu WL; Shen HL
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Apr; 19(2):337-41. PubMed ID: 21518484
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.